Quinoline Derivatives

The invention relates to quinoline compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, W, U, Q, R1, R5 R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the a...

Full description

Saved in:
Bibliographic Details
Main Authors ZECRI FREDERIC, SOLDERMANN NICOLAS, HURTH KONSTANZE, HOGENAUER KLEMENS, KALIS CHRISTOPH, MOEBITZ HENRIK
Format Patent
LanguageEnglish
Published 28.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to quinoline compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, wherein Y, W, U, Q, R1, R5 R7 and R30 are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
Bibliography:Application Number: US201214367417